ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Intravacc licences CimCure’s iBoost vaccine technology
July 03, 2020Dutch research and development vaccine institute Intravacc has collaborated with cancer immunotherapies developer CimCure to in-licence the latter’s iBoost technology for vaccines. -
Dutch Intravacc to in-license CimCure’s iBoost technology, expands its vaccine platform portfolio
July 02, 2020The iBoost (immune boost) technology was developed at Amsterdam UMC, lab-location VUMC, by Prof. Dr. Arjan Griffioen, professor of experimental oncology and CSO at CimCure.
Pharma Sources Insight January 2025
